BTCC / BTCC Square / Global Cryptocurrency /
Tesla Stock Faces Weekly Decline Amid Cybercab Manager Departure

Tesla Stock Faces Weekly Decline Amid Cybercab Manager Departure

Published:
2026-02-27 14:49:02
10
1
BTCCSquare news:

Tesla shares continued their downward trajectory, trading between $405 and $408 on Friday. The stock has declined approximately 5% since late January's earnings report, despite surpassing expectations. This marks three losing weeks out of the past four.

Victor Nechita's departure as Cybercab program manager adds pressure during a critical phase. His exit coincides with the first production unit rollout, though he praised his team's achievements in efficiency and safety. Tesla's ambitious robo-taxi plans target nine cities by mid-2026, trailing Waymo's existing ten-city operation.

Wall Street maintains a cautious stance, with analysts assigning a $396.80 average price target. Tesla's valuation remains stratospheric at 200 times projected 2026 earnings—tenfold the S&P 500's multiple.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users

All articles reposted on this platform are sourced from public networks and are intended solely for the purpose of disseminating industry information. They do not represent any official stance of BTCC. All intellectual property rights belong to their original authors. If you believe any content infringes upon your rights or is suspected of copyright violation, please contact us at [email protected]. We will address the matter promptly and in accordance with applicable laws.BTCC makes no explicit or implied warranties regarding the accuracy, timeliness, or completeness of the republished information and assumes no direct or indirect liability for any consequences arising from reliance on such content. All materials are provided for industry research reference only and shall not be construed as investment, legal, or business advice. BTCC bears no legal responsibility for any actions taken based on the content provided herein.